Biblio Bisciotti
2
3 S&C GIAN NICOLA BISCIOTTI - LA COMPONENTE GENETICA DELLE TENDINOPATIE E DELLE LESIONI DELL’ACHILLEO STRENGTH AND CONDITIONING. Per una scienza del movimento dell’uomo Maggio-Agosto 2012 BIBLIOGRAFIA 1. Ala-Kokko L. Genetic risk factors for lumbar disc dis- ease. Ann Med 2002;34:42–7 2. Aldred PM, Hollox EJ, Armour JA. Copy number poly- morphism and expression level variation of the human alpha-defensin genes DEFA1 and DEFA3. Hum Mol Genet 2005;14:2045–52 3. Alfredson H, Lorentzon M, Backman S et al. cDna-ar- rays and real-time quantitative PCR thecniques in the investigation of chronic Achilles tendinosis. J Orthop Res. 2003; 21: 970-975 4. Almekinders LC. Tendinitis and other chronic tendinopathies. J Am Acad Orthop Surg 1998;6:157– 64 5. Aroen A, Helgo D, Granlund OG, et al. Contralateral tendon rupture risk is increased in individuals with a previous Achilles tendon rupture. Scand J Med Sci Sports 2004;14:30–3 6. Bennett EP, Steffensen R, Clausen H, et al. Genomic cloning of the human histoblood group ABO locus. Biochem Biophys Res Commun 1995;206:18–25 7. Beyzade S, Zhang S, Wong YK et al. Influences of ma- trix metalloproteinase-3 gene variation on extend of coronary atherosclerosis and risk of myocardial infarc- tion. J Am Cool Cardiol. 2003; 41: 2130-2137 8. Birkedal-Hansen H, Moore WG, Bodden MK et al. Matrix metalloproteinases: a rewiew. Crit Rev Oral Biol Med. 1993; 4: 197-250 9. Bisciotti GN, Eirale C, Lello PP. ABO Blood Groups and Achilles Tendon Injury. Achilles tendon. Intech Publisher (Ed). Rijeka, Croatia. 2012 10. Bisciotti GN, Eirale C. The role of exogenous and en- dogenous factors in the etiology of Achilles and patellar tendinopathy. Med Sport. (submitted), 2011 11. Boot-Handford RP, Tuckwell DS, Plumb DA et al. A novel and highly conserved collagen (pro(alpha)1(XXVII)) with a unique expression pattern and unusual molecular characteristics establishes a new clade within the ver- tebrate fibrillar collagen family. J Biol Chem. 2003;278:31067–77 12. Caridi G, Pezzolo A, Bertelli R, Gimelli G, Di Donato A, Candiano G, Ghiggeri GM. Mapping the human COL5A1 gene to chromosome 9q34.3. Hum Genet. 1992; 90: 174-176 13. Chard MD, Harral RL, Curry VA et al. Rotator cuff degeneration and lateral epicondylitis: a comparative histological study. Ann Rheum Dis. 1994; 53: 30-34 14. Chiquet M, Fambrough DM. Chick myotendinous antigen. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J Cell Bio. 1984; 98: 1926- 1936 15. Corps AN, Harral RL, Curry VA et al. Ciprofloxacin enhances the simulation of matrix metalloproteinase 3 expression by interleukin 1beta in human tendon derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis Rheum. 2002; 46: 3034-3040 16. De Paepe A, Nuytinck L, Hausser I et al. Mutations in the COL5A1 gene are causal in the Ehlers-Danlos Syndromes I and II. Am J Hum Genet. 1997;60:547–54 17. Feuk L, Carson AR, Scherer SW. Structural varia- tion in the human genome. Nat Rev Genet 2006;7:85– 97 18. Flynn RK, Pedersen CL, Birmingham TB et al. The fa- milial predisposition toward tearing the anterior cruci- ate ligament: a case control study. Am J Sports Med. 2005;33:23–8 19. Freeman JL, Perry GH, Feuk L et al. Copy number variation: new insights in genome diversity. Genome Res 2006;16:949–61 20. Giunta C, Nuytinck L, Raghunath M et al. Homozy- gous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome. Am J Med Genet. 2002;109:284–90 21. Gonclaves-Neto J, Witzel SS, Teodoro WR, Car- valho-Junior AE, Fernandes TD, Yoshinari HH. Changes in collagen matrix composition in human posterior tibial tendon dysfunction. Joint Bone Spine. 2002; 69: 189- 194 22. Greenspan DS, Pasquinelli AE. BstUI and DpnII RFLPs at COL5A1 gene. Hum Mol Genet, 1994; 3: 385 23. Harvie P, Ostlere SJ, Teh J et al. Genetic influences in the aetiology of tears of the rotator cuff. Sibling risk of a full-thickness tear. J Bone Joint Surg Br. 2004;86:696–700 24. Ireland D, Harral R, Curry V et al. Multiple changes in gene expression in chronic human Achilles tendinopa- thy. Matrix Biol. 2001; 20: 159-169 25. Jarvinen TA, Jozsa L, Kannus P et al. Mechanical loading regulates tenascin-C expression in the osteo- tendinous junction. J Cell Sci 1999;112:3157–66 26. Jarvinen TA, Jozsa L, Kannus P et al. Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle. J Cell Sci. 2003;116:857–66 27. Jarvinen TA, Kannus P, Jarvinen TL et al. Tenascin-C in the pathobiology and healing process of musculoskele- tal tissue injury. Scand J Med Sci Sports. 2000;10:376–82 28. Jarvinen TA, Kannus P, Maffulli N et al. Achilles ten- don disorders: etiology and epidemiology. Foot Ankle Clin 2005;10:255–66 29. Jenkins E, Moss JB, Pace JM et al. The new colla- gen gene COL27A1 contains SOX9-responsive enhancer elements. Matrix Biol 2005;24:177–84 30. Jones FS, Jones PL. The tenascin family of ECM gly- coproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn. 2000;218:235–59 31. Jones GC, Corps AN, Pennington CJ et al. Expres- sion profiling of metalloproteinase and tissue inhibitors of metalloproteinase in normal and degenerate human Achilles tendon, Arthritis Rheum. 2006; 54: 832-842 32. Józsa L, Balint JB, Kannus P, Reffy A, Barzo M. Dis- tribution of blood groups in patients with tendon rup- ture. An analysis of 832 cases. J Bone Joint Surg. 1989; 71B: 272-274 33. Judge DP, Dietz HC. Marfan’s syndrome. Lancet 2005;366:1965–76 34. Kannus P, Jarvinen TL, Jarvinen TA et al. Painful Achilles tendon and its treatment. Scand J Med Sci Sports 2004;14:69–71 35. Kannus P, Natri A. Etiology and pathophysiology of tendon ruptures in sports. Scand J Med Sci Sports 1997;7:107–12 36. Kaushal GP, Shah SV. The new kids on the block: ADAMTSs, potentially multifunctional metalloproteinases of the ADAM family. J Clin Invest2000;105:1335–7 37. Kujala UM, Jarvinen M, Natri A et al. ABO blood groups and musculoskeletal injuries. Injury 1992;23:131–3 38. Leppilahti J, Puranen J, Orava S. ABO blood group and Achilles tendon rupture. Ann Chir Gynaecol 1996;85:369–71 39. Linzmeier RM, Ganz T. Copy number polymorphisms are not a common feature of innate immune genes. Ge- nomics 2006;88:122–6 40. Maffulli N, Ewen SW, Waterston SW, Reaper J, Barrass V. Tenocytes from ruptured and tendinopathic achilles tendons produce greater quantities of type III collagen than tenocytes from normal Achilles tendons: An in vitro model of human tendon healing. Am J Sports Med 2000; 28: 499–505 41. Maffulli N, Reaper JA, Waterston SW et al. ABO blood groups and Achilles tendon rupture in the Grampian region of Scotland. Clin J Sport Med2000;10:269–71 42. Mahrlein R, Schmelzeisen H, Papathanassopoulos A. Achillessehnenrupturen und blutgruppenzugehorigkeit. Aktuelle Traumatol 1995;25:13–15 43. Matsuda A, Hirota T, Akahoshi M et al. Coding SNP in tenascin-C Fn-III-D domain associates with adult asthma. Hum Mol Genet 2005a;14:2779–86 44. Matsuda A, Hirota T, Akahoshi M et al. Coding SNP in tenascin-C Fn-III-D domain associates with adult asthma. Hum Mol Genet 2005b;14:2779–86 45. Matziolis G, Drahn T, Perka C. Spontaneous patellar tendon rupture in a patient with Ehlers-Danlos syn- drome). Unfallchirurg. 2003;106:1051–3 46. Mazzone MF, McCue T. Common conditions of the Achilles tendon. Am Fam Physician 2002;65:1805–10 47. Mokone GG, Gajjar M, September AV et al. The Gua- nine-thymine dinucleotide repeat polymorphism within the tenascin-C gene is associated with Achilles tendon injuries. Am J Sports Med 2005;33:1016–21 48. Mokone GG, Schwellnus MP, Noakes TD et al. The COL5A1 gene and Achilles tendon pathology. Scand J Med Sci Sports 2006;16:19–26 49. Mokone GG. Risk factors for Achilles tendon in- juries: an emphasis on the identification of specific ge- netic factors. South Africa: University of Cape Town, 2006 50. Mokone GG, Schwellnus MP, Noakes TD, Collins M. The COL5A1 gene and Achilles tendon pathology. Scand J Med Sci Sport. 2006; 16: 19-26 51. Myllyharju J, Kivirikko KI. Collagens and collagen-re- lated disease: Ann Med. 2001; 33: 7-21 52. Noponen-Hietala N, Kyllonen E, Mannikko M et al. Sequence variations in the collagen IX and XI genes are associated with degenerative lumbar spinal stenosis. Ann Rheum Dis 2003;62:1208–14 53. Pace JM, Corrado M, Missero C et al. Identifica- tion, characterization and expression analysis of a new fibrillar collagen gene, COL27A Matrix Biol.2003;22:3– 14 54. Palmeri S, Mari F, Meloni I et al. Neurological pres- entation of Ehlers-Danlos syndrome type IV in a family with parental mosaicism. Clin Genet. 2003;63:510–15 55. Palvolgyi R, Balint BJ, Jozsa L. The Ehlers-Danlos syndrome causing lacerations in tendons and muscles. Arch Orthop Trauma Surg. 1979;95:173–6 56. Pierfitte C, Royer RJ. Tendon disorders with fluoro- quinolones. Terapie. 1996; 51: 419-420 57. Prockop DJ, Chu ML, de Wet W et al. Mutations in osteogenesis imperfecta leading to the synthesis of ab- normal type I procollagens. Ann N Y Acad Sci. 1985;460:289–97 58. Raleigh SM, Van der Merwe L, Ribbans Wj, Smith RK, Schwellnus MP, Collins M. Variant within the MMP3 gene are associated with Achilles tendinopathy: possible interaction whit the COL5A1 gene. Br J Sports Med. 2009; 43(7): 514-520. LA MACCHINA CHE C’È IN ME
-
Upload
eleonora-abbandoni -
Category
Documents
-
view
212 -
download
0
description
Strength & Conditioning 2
Transcript of Biblio Bisciotti
3
S&C
GIAN NICOLA BISCIOTTI - LA COMPONENTE GENETICA DELLE TENDINOPATIE E DELLE LESIONI DELL’ACHILLEO
STRENGTH AND CONDITIONING. Per una scienza del movimento dell’uomo Maggio-Agosto 2012
BIBLIOGRAFIA
1. Ala-Kokko L. Genetic risk factors for lumbar disc dis-ease. Ann Med 2002;34:42–7
2. Aldred PM, Hollox EJ, Armour JA. Copy number poly-morphism and expression level variation of the humanalpha-defensin genes DEFA1 and DEFA3. Hum Mol Genet2005;14:2045–52
3. Alfredson H, Lorentzon M, Backman S et al. cDna-ar-rays and real-time quantitative PCR thecniques in theinvestigation of chronic Achilles tendinosis. J OrthopRes. 2003; 21: 970-975
4. Almekinders LC. Tendinitis and other chronictendinopathies. J Am Acad Orthop Surg 1998;6:157–64
5. Aroen A, Helgo D, Granlund OG, et al. Contralateraltendon rupture risk is increased in individuals with aprevious Achilles tendon rupture. Scand J Med SciSports 2004;14:30–3
6. Bennett EP, Steffensen R, Clausen H, et al. Genomiccloning of the human histoblood group ABO locus.Biochem Biophys Res Commun 1995;206:18–25
7. Beyzade S, Zhang S, Wong YK et al. Influences of ma-trix metalloproteinase-3 gene variation on extend ofcoronary atherosclerosis and risk of myocardial infarc-tion. J Am Cool Cardiol. 2003; 41: 2130-2137
8. Birkedal-Hansen H, Moore WG, Bodden MK et al.Matrix metalloproteinases: a rewiew. Crit Rev Oral BiolMed. 1993; 4: 197-250
9. Bisciotti GN, Eirale C, Lello PP. ABO Blood Groups andAchilles Tendon Injury. Achilles tendon. Intech Publisher(Ed). Rijeka, Croatia. 2012
10. Bisciotti GN, Eirale C. The role of exogenous and en-dogenous factors in the etiology of Achilles and patellartendinopathy. Med Sport. (submitted), 2011
11. Boot-Handford RP, Tuckwell DS, Plumb DA et al. Anovel and highly conserved collagen (pro(alpha)1(XXVII))with a unique expression pattern and unusual molecularcharacteristics establishes a new clade within the ver-tebrate fibrillar collagen family. J Biol Chem.2003;278:31067–77
12. Caridi G, Pezzolo A, Bertelli R, Gimelli G, Di DonatoA, Candiano G, Ghiggeri GM. Mapping the humanCOL5A1 gene to chromosome 9q34.3. Hum Genet.1992; 90: 174-176
13. Chard MD, Harral RL, Curry VA et al. Rotator cuffdegeneration and lateral epicondylitis: a comparativehistological study. Ann Rheum Dis. 1994; 53: 30-34
14. Chiquet M, Fambrough DM. Chick myotendinousantigen. A monoclonal antibody as a marker for tendonand muscle morphogenesis. J Cell Bio. 1984; 98: 1926-1936
15. Corps AN, Harral RL, Curry VA et al. Ciprofloxacinenhances the simulation of matrix metalloproteinase 3expression by interleukin 1beta in human tendon derivedcells. A potential mechanism of fluoroquinolone-inducedtendinopathy. Arthritis Rheum. 2002; 46: 3034-3040
16. De Paepe A, Nuytinck L, Hausser I et al. Mutationsin the COL5A1 gene are causal in the Ehlers-DanlosSyndromes I and II. Am J Hum Genet. 1997;60:547–54
17. Feuk L, Carson AR, Scherer SW. Structural varia-tion in the human genome. Nat Rev Genet 2006;7:85–97
18. Flynn RK, Pedersen CL, Birmingham TB et al. The fa-milial predisposition toward tearing the anterior cruci-ate ligament: a case control study. Am J Sports Med.2005;33:23–8
19. Freeman JL, Perry GH, Feuk L et al. Copy numbervariation: new insights in genome diversity. Genome Res2006;16:949–61
20. Giunta C, Nuytinck L, Raghunath M et al. Homozy-gous Gly530Ser substitution in COL5A1 causes mildclassical Ehlers-Danlos syndrome. Am J Med Genet.2002;109:284–90
21. Gonclaves-Neto J, Witzel SS, Teodoro WR, Car-valho-Junior AE, Fernandes TD, Yoshinari HH. Changes incollagen matrix composition in human posterior tibialtendon dysfunction. Joint Bone Spine. 2002; 69: 189-194
22. Greenspan DS, Pasquinelli AE. BstUI and DpnIIRFLPs at COL5A1 gene. Hum Mol Genet, 1994; 3: 385
23. Harvie P, Ostlere SJ, Teh J et al. Genetic influencesin the aetiology of tears of the rotator cuff. Sibling riskof a full-thickness tear. J Bone Joint Surg Br.2004;86:696–700
24. Ireland D, Harral R, Curry V et al. Multiple changesin gene expression in chronic human Achilles tendinopa-thy. Matrix Biol. 2001; 20: 159-169
25. Jarvinen TA, Jozsa L, Kannus P et al. Mechanicalloading regulates tenascin-C expression in the osteo-tendinous junction. J Cell Sci 1999;112:3157–66
26. Jarvinen TA, Jozsa L, Kannus P et al. Mechanicalloading regulates the expression of tenascin-C in themyotendinous junction and tendon but does not inducede novo synthesis in the skeletal muscle. J Cell Sci.2003;116:857–66
27. Jarvinen TA, Kannus P, Jarvinen TL et al. Tenascin-Cin the pathobiology and healing process of musculoskele-tal tissue injury. Scand J Med Sci Sports.2000;10:376–82
28. Jarvinen TA, Kannus P, Maffulli N et al. Achilles ten-don disorders: etiology and epidemiology. Foot Ankle Clin2005;10:255–66
29. Jenkins E, Moss JB, Pace JM et al. The new colla-gen gene COL27A1 contains SOX9-responsive enhancerelements. Matrix Biol 2005;24:177–84
30. Jones FS, Jones PL. The tenascin family of ECM gly-coproteins: structure, function, and regulation duringembryonic development and tissue remodeling. Dev Dyn.2000;218:235–59
31. Jones GC, Corps AN, Pennington CJ et al. Expres-sion profiling of metalloproteinase and tissue inhibitorsof metalloproteinase in normal and degenerate humanAchilles tendon, Arthritis Rheum. 2006; 54: 832-842
32. Józsa L, Balint JB, Kannus P, Reffy A, Barzo M. Dis-tribution of blood groups in patients with tendon rup-ture. An analysis of 832 cases. J Bone Joint Surg.1989; 71B: 272-274
33. Judge DP, Dietz HC. Marfan’s syndrome. Lancet2005;366:1965–76
34. Kannus P, Jarvinen TL, Jarvinen TA et al. PainfulAchilles tendon and its treatment. Scand J Med SciSports 2004;14:69–71
35. Kannus P, Natri A. Etiology and pathophysiology oftendon ruptures in sports. Scand J Med Sci Sports1997;7:107–12
36. Kaushal GP, Shah SV. The new kids on the block:ADAMTSs, potentially multifunctional metalloproteinasesof the ADAM family. J Clin Invest2000;105:1335–7
37. Kujala UM, Jarvinen M, Natri A et al. ABO bloodgroups and musculoskeletal injuries. Injury1992;23:131–3
38. Leppilahti J, Puranen J, Orava S. ABO blood groupand Achilles tendon rupture. Ann Chir Gynaecol1996;85:369–71
39. Linzmeier RM, Ganz T. Copy number polymorphismsare not a common feature of innate immune genes. Ge-nomics 2006;88:122–6
40. Maffulli N, Ewen SW, Waterston SW, Reaper J,Barrass V. Tenocytes from ruptured and tendinopathicachilles tendons produce greater quantities of type IIIcollagen than tenocytes from normal Achilles tendons:An in vitro model of human tendon healing. Am J SportsMed 2000; 28: 499–505
41. Maffulli N, Reaper JA, Waterston SW et al. ABOblood groups and Achilles tendon rupture in theGrampian region of Scotland. Clin J SportMed2000;10:269–71
42. Mahrlein R, Schmelzeisen H, Papathanassopoulos A.Achillessehnenrupturen und blutgruppenzugehorigkeit.Aktuelle Traumatol 1995;25:13–15
43. Matsuda A, Hirota T, Akahoshi M et al. Coding SNPin tenascin-C Fn-III-D domain associates with adultasthma. Hum Mol Genet 2005a;14:2779–86
44. Matsuda A, Hirota T, Akahoshi M et al. Coding SNPin tenascin-C Fn-III-D domain associates with adultasthma. Hum Mol Genet 2005b;14:2779–86
45. Matziolis G, Drahn T, Perka C. Spontaneous patellartendon rupture in a patient with Ehlers-Danlos syn-drome). Unfallchirurg. 2003;106:1051–3
46. Mazzone MF, McCue T. Common conditions of theAchilles tendon. Am Fam Physician 2002;65:1805–10
47. Mokone GG, Gajjar M, September AV et al. The Gua-nine-thymine dinucleotide repeat polymorphism withinthe tenascin-C gene is associated with Achilles tendoninjuries. Am J Sports Med 2005;33:1016–21
48. Mokone GG, Schwellnus MP, Noakes TD et al. TheCOL5A1 gene and Achilles tendon pathology. Scand JMed Sci Sports 2006;16:19–26
49. Mokone GG. Risk factors for Achilles tendon in-juries: an emphasis on the identification of specific ge-netic factors. South Africa: University of Cape Town,2006
50. Mokone GG, Schwellnus MP, Noakes TD, Collins M.The COL5A1 gene and Achilles tendon pathology. ScandJ Med Sci Sport. 2006; 16: 19-26
51. Myllyharju J, Kivirikko KI. Collagens and collagen-re-lated disease: Ann Med. 2001; 33: 7-21
52. Noponen-Hietala N, Kyllonen E, Mannikko M et al.Sequence variations in the collagen IX and XI genes areassociated with degenerative lumbar spinal stenosis.Ann Rheum Dis 2003;62:1208–14
53. Pace JM, Corrado M, Missero C et al. Identifica-tion, characterization and expression analysis of a newfibrillar collagen gene, COL27A Matrix Biol.2003;22:3–14
54. Palmeri S, Mari F, Meloni I et al. Neurological pres-entation of Ehlers-Danlos syndrome type IV in a familywith parental mosaicism. Clin Genet. 2003;63:510–15
55. Palvolgyi R, Balint BJ, Jozsa L. The Ehlers-Danlossyndrome causing lacerations in tendons and muscles.Arch Orthop Trauma Surg. 1979;95:173–6
56. Pierfitte C, Royer RJ. Tendon disorders with fluoro-quinolones. Terapie. 1996; 51: 419-420
57. Prockop DJ, Chu ML, de Wet W et al. Mutations inosteogenesis imperfecta leading to the synthesis of ab-normal type I procollagens. Ann N Y Acad Sci.1985;460:289–97
58. Raleigh SM, Van der Merwe L, Ribbans Wj, SmithRK, Schwellnus MP, Collins M. Variant within the MMP3gene are associated with Achilles tendinopathy: possibleinteraction whit the COL5A1 gene. Br J Sports Med.2009; 43(7): 514-520.
LA MACCHINACHE C’È IN ME
Bibliografie_N°2_FIPCF-NSCA 27/07/12 09.24 Pagina 3
4
S&C
GIAN NICOLA BISCIOTTI - LA COMPONENTE GENETICA DELLE TENDINOPATIE E DELLE LESIONI DELL’ACHILLEO
STRENGTH AND CONDITIONING. Per una scienza del movimento dell’uomo Maggio-Agosto 2012
59. Rees JD, Wilson AM, Wolman RL. Current con-cepts in the management of tendon disorders.Rheumatology 2006;45:508–21
60. Riley GP. The pathogenesis of tendinopathy. A mo-lecular prospective. Reumatology. 2004; 43: 131-142
61. Riley GP, Curry V, DeGroot J et al. Matrix metallo-proteinase activities and their relationship with colla-gen remodelling in tendon pathology. Matrix Biol.2002; 21: 185-195
62. Riley GP. Chronic tendon pathology: molecularbasis and therapeutic implications. Expert Rev MolMed 2005a;7:1–25
63. Riley GP. Gene expression and matrix turnover inoverused and damaged tendons. Scand J Med SciSports 2005b;15:241–51
64. Schalkwijk J, Zweers MC, Steijlen PM et al. A re-cessive form of the Ehlers- Danlos syndrome caused bytenascin-X deficiency. N Engl J Med. 2001;345:1167–75
65. Schepsis AA, Jones H, Haas AL. Achilles tendondisorders in athletes. Am J Sports Med2002;30:287–30566. September AV, Mokone GG, Schwellnus MP et al.Genetic risk factors for Achilles tendon injuries. IntSports Med J 2006;7:201–15
67. September AV, Schwellnus MP, Collins M. Tendonand ligament injuries: the genetic component. Br JSport Med. 2007: 41: 241-246
68. Silver FH, Freeman JW, Seehra GP. Collagen self-assembly and the development of tendon mechanicalproperties. J Biomech. 2003; 36: 1529-1553
69. Solovieva S, Kouhia S, Leino-Arjas P et al. Inter-leukin 1 polymorphisms and intervertebral disc degen-eration. Epidemiology 2004;15:626–33
70. Solovieva S, Lohiniva J, Leino-Arjas P et al.COL9A3 gene polymorphism and obesity in interverte-bral disc degeneration of the lumbar spine: evidence ofgene environment interaction. Spine 2002;27:2691–6
71. Somerville RP, Oblander SA, Apte SS. Matrix met-alloproteinases: old dogs with new tricks. Genome Biol.2003; 4: 216. Surg 1998;6:157–64
72. Tilkeridis C, Bei T, Garantziotis S et al. Associationof a COL1A1 polymorphism with lumbar disc disease inyoung military recruits. J Med Genet 2005;42:e44
73. Thomopoulos S, Hattersley G, Rosen V et al. Thelocalized expression of extracellular matrix componentsin healing tendon insertion sites: an in situ hybridiza-tion study. J Orthop Res. 2002;20:454–63
74. Waterston SW, Maffulli N, Ewen SW. Subcuta-neous rupture of the Achilles tendon: basic science
and someaspects of clinical practice. Br J Sports Med.1997, 31(4):285–298.
75. Waterston SW. Histochemistry and biochemistryof Achilles tendon ruptures. University of Aberdeen;1997, 1–58.
76. Woo SL, Abramowitch SD, Kilger R et al. Biome-chanics of knee ligaments: injury, healing, and repair. JBiomech 2006;39:1–20
77. Ye S, Eriksson P, Hamsten A et al. Progression ofcoronary atherosclerosis is associated with a commongenetic variant of the human stromelysin-1 promoterwhich results in reduced gene expression. J Biol Chem.1996; 271: 13055-13060
78. Ye S, Patodi N, Walker-Bone K et al. Variation inthe matrix metalloproteinase-3, -7, -12 and 13 genesis associated with functional status in rheumatoidarthritis. In J Immunogenet. 2007; 34: 81-85
79. Young BB, Zhang G, Koch M, et al. The roles oftypes XII and XIV collagen in fibrillogenesis and matrixassembly in the developing cornea. J Cell Biochem.2002;87:208–20.
LA MACCHINACHE C’È IN ME
Bibliografie_N°2_FIPCF-NSCA 27/07/12 09.24 Pagina 4
